Market Cap

Entera Bio Ltd. Market Capitalization:

$81.2 Million

USD as of Jan. 1, 2026

business Entera Bio Ltd. Company Profile

Entera Bio Ltd. Main Stock Listing

NASDAQ: ENTX

Market Capitalization History of Entera Bio Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Entera Bio Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $81.2 M -8.18%
Jan. 1, 2025 $88.4 M 31566.13%
Jan. 1, 2024 $279,154 9.98%
Jan. 1, 2023 $253,815 -61.53%
Jan. 1, 2022 $659,746 56.85%
Jan. 1, 2021 $420,624 -53.65%
Jan. 1, 2020 $907,511 -21.25%
Jan. 1, 2019 $1.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Entera Bio Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

Entera Bio Ltd. has the following listings and related stock indices.


Stock: NASDAQ: ENTX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.